Stock Analysis

With 78% ownership, Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017) insiders have a lot riding on the company's future

SASE:4017
Source: Shutterstock

Key Insights

  • Dr. Soliman Abdel Kader Fakeeh Hospital's significant insider ownership suggests inherent interests in company's expansion
  • The top 2 shareholders own 62% of the company
  • Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business

A look at the shareholders of Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 78% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

So it follows, every decision made by insiders of Dr. Soliman Abdel Kader Fakeeh Hospital regarding the company's future would be crucial to them.

Let's delve deeper into each type of owner of Dr. Soliman Abdel Kader Fakeeh Hospital, beginning with the chart below.

Check out our latest analysis for Dr. Soliman Abdel Kader Fakeeh Hospital

ownership-breakdown
SASE:4017 Ownership Breakdown September 17th 2024

What Does The Lack Of Institutional Ownership Tell Us About Dr. Soliman Abdel Kader Fakeeh Hospital?

Small companies that are not very actively traded often lack institutional investors, but it's less common to see large companies without them.

There are many reasons why a company might not have any institutions on the share registry. It may be hard for institutions to buy large amounts of shares, if liquidity (the amount of shares traded each day) is low. If the company has not needed to raise capital, institutions might lack the opportunity to build a position. Alternatively, there might be something about the company that has kept institutional investors away. Dr. Soliman Abdel Kader Fakeeh Hospital's earnings and revenue track record (below) may not be compelling to institutional investors -- or they simply might not have looked at the business closely.

earnings-and-revenue-growth
SASE:4017 Earnings and Revenue Growth September 17th 2024

Dr. Soliman Abdel Kader Fakeeh Hospital is not owned by hedge funds. With a 31% stake, CEO Mazen Soliman Abdel Fakeeh is the largest shareholder. With 31% and 16% of the shares outstanding respectively, Ammar Soliman Abdel Fakeeh and Manal Soliman Abdel Fakeeh are the second and third largest shareholders. Interestingly, the third-largest shareholder, Manal Soliman Abdel Fakeeh is also a Vice Chairman, again, indicating strong insider ownership amongst the company's top shareholders.

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Dr. Soliman Abdel Kader Fakeeh Hospital

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

It seems that insiders own more than half the Dr. Soliman Abdel Kader Fakeeh Hospital Company stock. This gives them a lot of power. That means insiders have a very meaningful ر.س10b stake in this ر.س13b business. It is good to see this level of investment. You can check here to see if those insiders have been selling any of their shares.

General Public Ownership

The general public, who are usually individual investors, hold a 22% stake in Dr. Soliman Abdel Kader Fakeeh Hospital. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Dr. Soliman Abdel Kader Fakeeh Hospital better, we need to consider many other factors.

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.